Manoj Maniar - Fremont CA, US Janice W Bell - Narberth PA, US
Assignee:
Onconova Therapeutics, Inc - Newtown PA
International Classification:
A61K 31/10
US Classification:
514710
Abstract:
Formulations are provided for parenteral administration of (amino substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones and the sodium and potassium salts thereof for the prevention and/or treatment of conditions mediated by abnormal cell proliferation. Composition for parenteral administration are provided which comprise an effective amount of a compound of formula I.
Formulation Of Radioprotective Alpha Beta Unsaturated Aryl Sulfones
A pharmaceutical composition is provided for administration prior to or after exposure to ionizing radiation for reducing toxic effects of the radiation in a subject. An effective amount of the pharmaceutical composition provided comprising an effective amount of at least one radioprotective α, β unsaturated aryl sulfone, and at least one component selected from the group consisting of a) at least one water soluble polymer in an amount between about 0.5% and about 90% w/v, b) at least one chemically modified cyclodextrin in an amount between about 20% and about 60% w/v, and c) DMA in an amount between about 10% and about 50% w/v.
I am a nurse educator and registered psychologist who provides international leadership in the field of Family Health with a particular focus on Family Systems Nursing theory, practice, and research. ...